We expected that 25% of
patients would have CTC and a recurrence rate of 10%
in the CTC-negative group and 20% in the CTC-positive
group. For 80% power we calculated a sample size of
500 patients. A minimal follow-up period of six months
was chosen. Body Mass Index was not captured and
thus not considered in our analysis.